#USA #Irvine #FDA Clearance #Bright Uro #Glean Urodynamics

Bright Uro Unveils Glean® Abdominal Sensor with FDA Clearance

In a groundbreaking advancement for urodynamics, Bright Uro, an innovative medical device company, has received FDA 510(k) clearance for its Glean® Abdominal Sensor. This new technology enhances the existing Glean® Urodynamics System, expanding its capabilities to perform multi-channel urodynamic studies. The Glean system is specifically designed for patients suffering from lower urinary tract dysfunction (LUTD), transforming urodynamic testing into a more efficient and patient-friendly process.

Revolutionizing Urodynamic Testing

The Glean® Abdominal Sensor enables a wireless, catheter-free option for conducting ambulatory urodynamics. Traditionally, urodynamic testing has involved uncomfortable catheter-based methods that could yield less accurate data. The introduction of this sensor not only improves patient comfort but also enhances the accuracy of the information collected during urodynamic studies. As many as 80 million Americans experience voiding issues ranging from overactive bladder to urinary incontinence. The innovative Glean system addresses these concerns by offering reliable data that facilitates better-informed treatment strategies.

Dr. Siobhan Hartigan from Hunterdon Health in New Jersey states, "Glean has been my preferred urodynamics technology since the very first use. The addition of abdominal pressure monitoring and full multi-channel urodynamics has broadened its clinical value in my practice." This claim mirrors the sentiment among patients, who reportedly prefer Glean's more dignified testing methods over conventional approaches.

A Commitment to Innovation

Bright Uro’s CEO and Founder, Derek Herrera, emphasizes the company's mission to enhance the urodynamics experience for both clinicians and patients. “The Abdominal Sensor launch exemplifies our commitment to innovation and responsiveness to customer needs,” he noted. This development is particularly timely, as healthcare professionals actively seek methods to streamline diagnostic procedures and improve clinical outcomes.

Following its initial commercial launch, the Glean system has rapidly gained traction in the U.S. market, with many healthcare providers considering it a superior alternative for conducting cystometry and pressure flow studies. The recent clearance to include the abdominal sensor demonstrates Bright Uro's proactive approach to refining its products based on user feedback and clinical requirements.

Understanding Urodynamics

Urodynamics itself involves a set of tests that measure how well the bladder and urethra store and release urine. It helps in diagnosing conditions like urinary incontinence and abnormal urinary retention. The Glean® Urodynamics System is unique—it is the first to offer wireless, catheter-free examinations, providing a dignified experience for patients while allowing clinicians to obtain more precise data needed for effective diagnosis.

Bright Uro holds an exclusive licensing agreement with Cleveland Clinic for the technology and utilizes insights from various esteemed medical institutions including the Department of Veterans Affairs and Case Western Reserve University. This collaboration is rooted in a vision to refine urological care through innovative medical devices tailored for the needs of both patients and healthcare providers.

Future Directions

As Bright Uro prepares to launch the first cases with the Glean® Abdominal Sensor in Q3, the anticipation is high within the medical community. This advancement not only signifies a technological leap in urological diagnostics but highlights the broader trend towards patient-centered healthcare solutions. The integration of this innovative sensor into everyday clinical practice promises to redefine how urologie issues are managed, one study at a time.

For more detailed information about the Glean Urodynamics System and its applications, visit GleanUDS.com.

As healthcare continues to evolve, Bright Uro's commitment to providing superior diagnostic instruments marks a crucial step forward in improving patient care and making urodynamic testing a more pleasant experience. The future of urology is indeed bright with the introduction of the Glean® Abdominal Sensor.